ALEXANDRIA, Va., May 19 -- United States Patent no. 12,631,634, issued on May 19, was assigned to Ventana Medical Systems Inc. (Tucson, Ariz.).
"Histochemical and cytochemical methods for detecting NTRK fusion proteins" was invented by Janine Feng (New York), Frances Hansen (Tucson, Ariz.), Linda Kivi (Marana, Ariz.), Patricia Nuzzo (Tucson, Ariz.), John Palting (Tucson, Ariz.) and John Pate (Oro Valley, Ariz.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Materials and methods for detecting NTRK rearrangements via affinity staining. Samples are stained with a biomarker-specific reagent (such as an antibody) that binds to a retained portion of TrkA, TrkB, and/or TrkC. The staining pattern is evaluated, and t...